BRK-B vs FVCB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
FVCB presents a compelling value opportunity, trading significantly below its Graham Number ($19.71) and Intrinsic Value ($35.99). The company maintains a stable financial health profile with a Piotroski F-Score of 4/9 and strong double-digit growth in both revenue (10.20%) and earnings (15.20%). While insider sentiment is bearish and technical trends are currently weak, the fundamental valuation metrics (P/E 12.89, P/B 1.10) suggest the stock is undervalued. The extremely low dividend payout ratio of 9.92% provides a significant cushion for future dividend growth.
Compare Another Pair
Related Comparisons
BRK-B vs FVCB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and FVCBankcorp, Inc. (FVCB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.